Previous 10 | Next 10 |
InflaRx (NASDAQ: IFRX ): Q1 GAAP EPS of -€0.32 beats by €0.20 . Cash, cash equivalents and financial assets of approximately €108M. Shares +1.4% . Press Release More news on: InflaRx N.V., Earnings news and commentary, Healthcare stocks news, ,
End of Phase II meeting with the FDA scheduled to discuss the path forward for IFX-1 in Hidradenitis Suppurativa Initial promising results reported in Pyoderma Gangraenosum Part 1 of adaptive randomized trial in severe COVID-19 pneumonia fully enrolled Signed clinical collaboration agr...
LMP Automotive Holdings (NASDAQ: LMPX ) +35% . More news on: LMP Automotive Holdings, Inc., AgEagle Aerial Systems, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
Citing "imminent data" from its COVID-19 trial and an autoimmune disorder study, Raymond James' Steven Seedhouse has upgraded InflaRx (NASDAQ: IFRX ) to Outperform with a $10 (85% upside) price target. More news on: InflaRx N.V., Healthcare stocks news, Stocks on the move, Read more .....
InflaRx (NASDAQ: IFRX ): FY GAAP EPS of -€2.05 beats by €0.08 . More news on: InflaRx N.V., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
End of Phase 2 FDA meeting scheduled to discuss the path forward for IFX-1 in Hidradenitis Suppurativa Initial promising results reported in Pyoderma Gangraenosum Part 1 of adaptive randomized trial in severe COVID-19 pneumonia fully enrolled Executed clinical collaboration agreement in...
Luckin Coffee (NASDAQ: LK ) -84% on fraud finding . More news on: Luckin Coffee Inc., Golar LNG Partners LP, Safe-T Group Ltd, Stocks on the move, , Read more ...
Gainers: Safe-T Group (NASDAQ: SFET ) +110% . More news on: Safe-T Group Ltd, Datasea Inc., NeuroMetrix, Inc., Stocks on the move, , Read more ...
All Jokes Aside, Are These Penny Stocks On Your Radar? The S&P 500 rolled over on March 31 after trying to hold gains for most of the session. But despite the Dow having its worst quarter in recorded history, penny stocks were some of the top performers. You can’t argue the fact t...
Gainers: IFRX +40.1% . CERS +9.9% . NVAX +8.3% . TWOU +4.7% . More news on: InflaRx N.V., Cerus Corporation, Novavax, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced today that GOHIBIC (vilobelimab) has been selected by the Biomedical Advanced Research and Development ...
Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential differentiation and medical role of INF904 in initially targeted indications and inflammation & imm...
JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American Thoracic Society (ATS) 2024 International Conference that is being held f...